Cargando…
Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy
The anti-metabolite drug gemcitabine is widely used for the treatment of a variety of cancers. At present, gemcitabine is administered as a hydrochloride salt that is delivered by slow intravenous injection in cycles of three or four weeks. Although regarded as a ‘front-line’ chemotherapeutic agent,...
Autores principales: | Habib, Saffiya, Singh, Moganavelli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997169/ https://www.ncbi.nlm.nih.gov/pubmed/33673636 http://dx.doi.org/10.3390/nano11030597 |
Ejemplares similares
-
Angiopep-2-Modified Nanoparticles for Brain-Directed Delivery of Therapeutics: A Review
por: Habib, Saffiya, et al.
Publicado: (2022) -
Anti-c-myc RNAi-Based Onconanotherapeutics
por: Habib, Saffiya, et al.
Publicado: (2020) -
Recent Development of Prodrugs of Gemcitabine
por: Pandit, Bhoomika, et al.
Publicado: (2022) -
Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019) -
Nanosystems for chemodynamic based combination therapy: Strategies and recent advances
por: Li, Minghui, et al.
Publicado: (2022)